Kavar Capital Partners Group’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,746	Closed	-$35K	–	416
2019 Q2	$35K	Buy	+3,746	New	+$45.2K	0.01%	264
2018 Q3	–	Sell	-3,468	Closed	-$84K	–	347
2018 Q2	$84K	Hold	3,468	–	–	0.04%	150
2018 Q1	$59K	Buy	+3,468	New	+$67.7K	0.03%	173
2017 Q3	–	Sell	-30,072	Closed	-$999K	–	113
2017 Q2	$999K	Sell	30,072 -1,256	-4%	-$38.9K	0.54%	67
2017 Q1	$1M	Buy	31,328 +1,112	+4%	+$37.9K	0.56%	67
2016 Q4	$1.09M	Sell	30,216 -13,472	-31%	-$538K	0.69%	61
2016 Q3	$2.01M	Buy	43,688 +1,110	+3%	+$57.9K	1.3%	28
2016 Q2	$2.14M	Buy	42,578 +3,405	+9%	+$181K	1.38%	25
2016 Q1	$2.1M	Buy	39,173 +4,507	+13%	+$264K	1.39%	22
2015 Q4	$2.27M	Buy	34,666 +4,657	+16%	+$288K	1.46%	17
2015 Q3	$1.69M	Buy	30,009 +695	+2%	+$45.1K	1.2%	30
2015 Q2	$1.73M	Buy	29,314 +4,693	+19%	+$290K	1.18%	32
2015 Q1	$1.53M	Buy	24,621 +2,037	+9%	+$118K	1.3%	30
2014 Q4	$1.3M	Sell	22,584 -400	-2%	-$22.3K	1.02%	42
2014 Q3	$1.24M	Sell	22,984 -1,125	-5%	-$59.6K	1.06%	34
2014 Q2	$1.26M	Hold	24,109	–	–	1.07%	27
2014 Q1	$1.27M	Buy	24,109 +91	+0.4%	+$4.21K	1.05%	23
2013 Q4	$962K	Buy	+24,018	New	+$946K	0.86%	47